Arkadios Wealth Advisors’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-190
Closed -$18K 948
2021
Q3
$18K Sell
190
-1,311
-87% -$138K ﹤0.01% 1249
2021
Q2
$186K Buy
+1,501
New +$179K 0.02% 548
2020
Q3
Sell
-47
Closed -$4.37K 1037
2020
Q2
$4.37K Buy
+47
New +$3.75K ﹤0.01% 798

Other funds holding EXAS

Arkadios Wealth Advisors's EXAS Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 190 shares — an estimated $18K sold.

Arkadios Wealth Advisors first reported a position in EXAS in Q2 2020 and held it in 3 quarters. The position peaked at $186K in Q2 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 190 Exact Sciences shares in Q4 2021, an estimated $18K.
  • Arkadios Wealth Advisors first reported a position in Exact Sciences in Q2 2020 and held it in 3 quarters.
  • Arkadios Wealth Advisors's Exact Sciences position peaked at $186K in Q2 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.